{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:08:51Z","timestamp":1788480531346,"version":"build-2803163510"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11005-0","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T12:11:55Z","timestamp":1758111115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling Non-coding RNAs and dysregulation of TGF-\u03b2 signalling in cardiorenal syndrome, a focused review for molecular and clinical applications"],"prefix":"10.1007","volume":"52","author":[{"given":"Manpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muskan","family":"Middha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2743-1487","authenticated-orcid":false,"given":"Varsha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"11005_CR1","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1111\/bph.15065","volume":"177","author":"F Savira","year":"2020","unstructured":"Savira F, Magaye R, Liew D et al (2020) Cardiorenal syndrome: multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol 177:2906\u20132922","journal-title":"Br J Pharmacol"},{"key":"11005_CR2","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/ehf2.14520","volume":"10","author":"SC Ru","year":"2023","unstructured":"Ru SC, Lv S, Bin, Li ZJ (2023) Incidence, mortality, and predictors of acute kidney injury in patients with heart failure: a systematic review. ESC Hear Fail 10:3237\u20133249. https:\/\/doi.org\/10.1002\/ehf2.14520","journal-title":"ESC Hear Fail"},{"key":"11005_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12882-024-03914-2","volume":"25","author":"Y Mezgebu","year":"2024","unstructured":"Mezgebu Y, Alemu S, Mohamed MA et al (2024) Acute kidney injury and its associated factors among patients with acute decompensated heart failure admitted to the university of Gondar hospital, Northwest Ethiopia: a hospital-based cross-sectional study. BMC Nephrol 25:461. https:\/\/doi.org\/10.1186\/s12882-024-03914-2","journal-title":"BMC Nephrol"},{"key":"11005_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000497748","volume":"9","author":"GM Virz\u00ec","year":"2019","unstructured":"Virz\u00ec GM, Clementi A, Battaglia GG, Ronco C (2019) Multi-omics approach: new potential key mechanisms implicated in cardiorenal syndromes. CardioRenal Med 9:201\u2013211. https:\/\/doi.org\/10.1159\/000497748","journal-title":"CardioRenal Med"},{"key":"11005_CR5","doi-asserted-by":"publisher","first-page":"889553","DOI":"10.3389\/fcvm.2022.889553","volume":"9","author":"B Gabbin","year":"2022","unstructured":"Gabbin B, Meraviglia V, Mummery CL et al (2022) Toward human models of cardiorenal syndrome in vitro. Front Cardiovasc Med 9:889553. https:\/\/doi.org\/10.3389\/fcvm.2022.889553","journal-title":"Front Cardiovasc Med"},{"key":"11005_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fphys.2015.00082","volume":"6","author":"XM Meng","year":"2015","unstructured":"Meng XM, Tang PMK, Li J, Lan HY (2015) TGF-\u00df\/Smad signaling in renal fibrosis. Front Physiol 6:82. https:\/\/doi.org\/10.3389\/fphys.2015.00082","journal-title":"Front Physiol"},{"key":"11005_CR7","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massagu\u00e9","year":"2023","unstructured":"Massagu\u00e9 J, Sheppard D (2023) TGF-\u03b2 signaling in health and disease. Cell 186:4007\u20134037","journal-title":"Cell"},{"key":"11005_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cytogfr.2004.11.002","volume":"16","author":"A S\u00e1nchez-Capelo","year":"2005","unstructured":"S\u00e1nchez-Capelo A (2005) Dual role for TGF-\u03b21 in apoptosis. Cytokine Growth Factor Rev 16:15\u201334. https:\/\/doi.org\/10.1016\/j.cytogfr.2004.11.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"11005_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","volume":"48","author":"RM Liu","year":"2010","unstructured":"Liu RM, Gaston Pravia KA (2010) Oxidative stress and glutathione in TGF-\u03b2-mediated fibrogenesis. Free Radic Biol Med 48:1\u201315","journal-title":"Free Radic Biol Med"},{"key":"11005_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10557-023-07531-3","volume":"39","author":"Z Chen","year":"2025","unstructured":"Chen Z, Cheng Z, Ding C et al (2025) ROS-activated TRPM2 channel: calcium homeostasis in cardiovascular\/renal system and speculation in cardiorenal syndrome. Cardiovasc Drugs Ther 39:615\u2013631. https:\/\/doi.org\/10.1007\/s10557-023-07531-3","journal-title":"Cardiovasc Drugs Ther"},{"key":"11005_CR11","first-page":"251","volume":"37","author":"U Kumar","year":"2019","unstructured":"Kumar U, Wettersten N, Garimella PS (2019) Cardiorenal syndrome: pathophysiology. Cardiol Clin 37:251\u2013265","journal-title":"Cardiol Clin"},{"key":"11005_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","volume":"51","author":"JN Peoples","year":"2019","unstructured":"Peoples JN, Saraf A, Ghazal N et al (2019) Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med 51:1\u20133. https:\/\/doi.org\/10.1038\/s12276-019-0355-7","journal-title":"Exp Mol Med"},{"key":"11005_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/cells11050844","volume":"11","author":"K Lipke","year":"2022","unstructured":"Lipke K, Kubis-Kubiak A, Piwowar A (2022) Molecular mechanism of lipotoxicity as an interesting aspect in the development of pathological states\u2014current view of knowledge. Cells 11:844. https:\/\/doi.org\/10.3390\/cells11050844","journal-title":"Cells"},{"key":"11005_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01476-z","author":"B Zhao","year":"2025","unstructured":"Zhao B, Hu X, Wang W et al (2025) Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies. Acta Pharmacol Sin. https:\/\/doi.org\/10.1038\/s41401-025-01476-z","journal-title":"Acta Pharmacol Sin"},{"key":"11005_CR15","doi-asserted-by":"publisher","first-page":"932693","DOI":"10.3389\/fphys.2022.932693","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, Ma K, Zhang Y et al (2022) Kidney diseases and long non-coding RNAs in the limelight. Front Physiol 13:932693. https:\/\/doi.org\/10.3389\/fphys.2022.932693","journal-title":"Front Physiol"},{"key":"11005_CR16","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","volume":"39","author":"W Poller","year":"2018","unstructured":"Poller W, Dimmeler S, Heymans S et al (2018) Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J 39:2704\u20132716. https:\/\/doi.org\/10.1093\/eurheartj\/ehx165","journal-title":"Eur Heart J"},{"key":"11005_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12040773","author":"ON Buliga-Finis","year":"2022","unstructured":"Buliga-Finis ON, Ouatu A, Badescu MC et al (2022) Beyond the cardiorenal syndrome: pathophysiological approaches and biomarkers for renal and cardiac crosstalk. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics12040773","journal-title":"Diagnostics"},{"key":"11005_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1567994","author":"M Yao","year":"2025","unstructured":"Yao M, Liu Z, Zhao W et al (2025) Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1567994","journal-title":"Front Immunol"},{"key":"11005_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22:96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11005_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fgene.2020.00150","volume":"11","author":"T Qin","year":"2020","unstructured":"Qin T, Li J, Zhang KQ (2020) Structure, regulation, and function of linear and circular long Non-Coding RNAs. Front Genet 11:150. https:\/\/doi.org\/10.3389\/fgene.2020.00150","journal-title":"Front Genet"},{"key":"11005_CR21","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.26355\/eurrev_202003_20532","volume":"24","author":"LY Qin","year":"2020","unstructured":"Qin LY, Wang MX, Zhang H (2020) Mir-133a alleviates renal injury caused by sepsis by targeting BNIP3L. Eur Rev Med Pharmacol Sci 24:2632\u20132639. https:\/\/doi.org\/10.26355\/eurrev_202003_20532","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11005_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25:211\u2013232. https:\/\/doi.org\/10.1038\/s41576-023-00662-1","journal-title":"Nat Rev Genet"},{"key":"11005_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/antiox12020262","volume":"12","author":"J Infante-Men\u00e9ndez","year":"2023","unstructured":"Infante-Men\u00e9ndez J, Gonz\u00e1lez-L\u00f3pez P, Huertas-L\u00e1rez R et al (2023) Oxidative stress modulation by NcRNAs and their emerging role as therapeutic targets in atherosclerosis and non-alcoholic fatty liver disease. Antioxidants 12:262. https:\/\/doi.org\/10.3390\/antiox12020262","journal-title":"Antioxidants"},{"key":"11005_CR24","doi-asserted-by":"publisher","DOI":"10.48101\/ujms.v129.10614","volume":"129","author":"DM Rodrigues-Junior","year":"2024","unstructured":"Rodrigues-Junior DM, Moustakas A (2024) Unboxing the network among long non-coding RNAs and TGF-\u03b2 signaling in cancer. Ups J Med Sci 129:10\u201348101. https:\/\/doi.org\/10.48101\/ujms.v129.10614","journal-title":"Ups J Med Sci"},{"key":"11005_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1681\/ASN.2010020134","volume":"21","author":"ACK Chung","year":"2010","unstructured":"Chung ACK, Huang XR, Meng X, Lan HY (2010) MiR-192 mediates TGF-\u03b2\/Smad3-driven renal fibrosis. J Am Soc Nephrol 21:1317\u20131325. https:\/\/doi.org\/10.1681\/ASN.2010020134","journal-title":"J Am Soc Nephrol"},{"key":"11005_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19071901","volume":"19","author":"HI Suzuki","year":"2018","unstructured":"Suzuki HI (2018) Microrna control of TGF-\u03b2 signaling. Int J Mol Sci 19:1901. https:\/\/doi.org\/10.3390\/ijms19071901","journal-title":"Int J Mol Sci"},{"key":"11005_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8319283","volume":"2016","author":"A Loboda","year":"2016","unstructured":"Loboda A, Sobczak M, Jozkowicz A, Dulak J (2016) TGF- \u03b2 1\/smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm 2016:8319283. https:\/\/doi.org\/10.1155\/2016\/8319283","journal-title":"Mediators Inflamm"},{"key":"11005_CR28","doi-asserted-by":"publisher","first-page":"E840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA et al (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139:E840\u2013E878. https:\/\/doi.org\/10.1161\/CIR.0000000000000664","journal-title":"Circulation"},{"key":"11005_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111581","author":"G Gembillo","year":"2021","unstructured":"Gembillo G, Visconti L, Giusti MA et al (2021) Cardiorenal syndrome: new pathways and novel biomarkers. Biomolecules. https:\/\/doi.org\/10.3390\/biom11111581","journal-title":"Biomolecules"},{"key":"11005_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000335499","volume":"2","author":"GM Virz\u00ec","year":"2012","unstructured":"Virz\u00ec GM, Torregrossa R, Cruz DN et al (2012) Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med 2:33\u201342. https:\/\/doi.org\/10.1159\/000335499","journal-title":"Cardiorenal Med"},{"key":"11005_CR31","first-page":"5703","volume":"10","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Zhou Y (2017) Circulating miR-21 and miR-423-5p as biomarkers for heart failure in heart valve disease patients. Int J Clin Exp Pathol 10:5703\u20135711","journal-title":"Int J Clin Exp Pathol"},{"key":"11005_CR32","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1038\/s41598-017-04040-w","volume":"7","author":"T Keller","year":"2017","unstructured":"Keller T, Boeckel JN, Gro\u00df S et al (2017) Improved risk stratification in prevention by use of a panel of selected circulating MicroRNAs. Sci Rep 7:4511. https:\/\/doi.org\/10.1038\/s41598-017-04040-w","journal-title":"Sci Rep"},{"key":"11005_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/11779322211027396","author":"R Ishrat","year":"2021","unstructured":"Ishrat R, Ahmed MM, Tazyeen S et al (2021) In silico integrative approach revealed key MicroRNAs and associated target genes in cardiorenal syndrome. Bioinform Biol Insights. https:\/\/doi.org\/10.1177\/11779322211027396","journal-title":"Bioinform Biol Insights"},{"key":"11005_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12872-024-03816-z","volume":"24","author":"Y Zong","year":"2024","unstructured":"Zong Y, Hu Y, Zheng M, Wang Z (2024) Bioinformatics analysis of the MicroRNA genes associated with type 2 cardiorenal syndrome. BMC Cardiovasc Disord 24:142. https:\/\/doi.org\/10.1186\/s12872-024-03816-z","journal-title":"BMC Cardiovasc Disord"},{"key":"11005_CR35","doi-asserted-by":"publisher","unstructured":"Gao S, Dong Y, Yan C et al (2023) The role of exosomes and exosomal microRNA in diabetic cardiomyopathy. Front Endocrinol (Lausanne) 14. https:\/\/doi.org\/10.3389\/fendo.2023.1327495","DOI":"10.3389\/fendo.2023.1327495"},{"key":"11005_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/erc.12.26","volume":"10","author":"PR Taub","year":"2012","unstructured":"Taub PR, Borden KC, Fard A, Maisel A (2012) Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome. Expert Rev Cardiovasc Ther 10:657\u2013667","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"11005_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol E, B\u00f6ing AN, Harrison P et al (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64:676\u2013705. https:\/\/doi.org\/10.1124\/pr.112.005983","journal-title":"Pharmacol Rev"},{"key":"11005_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1681\/ASN.2008060564","volume":"20","author":"MC Hogan","year":"2009","unstructured":"Hogan MC, Manganelli L, Woollard JR et al (2009) Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol 20:278\u2013288. https:\/\/doi.org\/10.1681\/ASN.2008060564","journal-title":"J Am Soc Nephrol"},{"key":"11005_CR39","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1111\/j.1582-4934.2012.01523.x","volume":"16","author":"J Wang","year":"2012","unstructured":"Wang J, Huang W, Xu R et al (2012) MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 16:2150\u20132160. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01523.x","journal-title":"J Cell Mol Med"},{"key":"11005_CR40","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/157016111797484143","volume":"9","author":"J Heyn","year":"2011","unstructured":"Heyn J, Hinske C, Mohnle P et al (2011) Micrornas as potential therapeutic agents in the treatment of myocardial infarction. Curr Vasc Pharmacol 9:733\u2013740. https:\/\/doi.org\/10.2174\/157016111797484143","journal-title":"Curr Vasc Pharmacol"},{"key":"11005_CR41","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.7150\/thno.37678","volume":"10","author":"L Gao","year":"2020","unstructured":"Gao L, Mei S, Zhang S et al (2020) Cardio-renal exosomes in myocardial infarction serum regulate proangiogenic paracrine signaling in adipose mesenchymal stem cells. Theranostics 10:1060\u20131073. https:\/\/doi.org\/10.7150\/thno.37678","journal-title":"Theranostics"},{"key":"11005_CR42","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang C, Batkai S, Dangwal S et al (2014) Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124:2136\u20132146. https:\/\/doi.org\/10.1172\/JCI70577","journal-title":"J Clin Invest"},{"key":"11005_CR43","doi-asserted-by":"publisher","first-page":"837270","DOI":"10.3389\/fcvm.2022.837270","volume":"9","author":"S Shi","year":"2022","unstructured":"Shi S, Zhang B, Li Y et al (2022) Mitochondrial dysfunction: an emerging link in the pathophysiology of cardiorenal syndrome. Front Cardiovasc Med 9:837270. https:\/\/doi.org\/10.3389\/fcvm.2022.837270","journal-title":"Front Cardiovasc Med"},{"key":"11005_CR44","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1074\/jbc.M109.082610","volume":"285","author":"H Nishi","year":"2010","unstructured":"Nishi H, Ono K, Iwanaga Y et al (2010) Microrna-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem 285:4920\u20134930. https:\/\/doi.org\/10.1074\/jbc.M109.082610","journal-title":"J Biol Chem"},{"key":"11005_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/HYPERTENSIONAHA.109.145136","volume":"55","author":"X Zhou","year":"2010","unstructured":"Zhou X, Ma L, Habibi J et al (2010) Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. Hypertension 55:880\u2013888. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.145136","journal-title":"Hypertension"},{"key":"11005_CR46","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.molcel.2010.05.018","volume":"38","author":"R Schickel","year":"2010","unstructured":"Schickel R, Park SM, Murmann AE, Peter ME (2010) mir-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell 38:908\u2013915. https:\/\/doi.org\/10.1016\/j.molcel.2010.05.018","journal-title":"Mol Cell"},{"key":"11005_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013614","author":"S Oba","year":"2010","unstructured":"Oba S, Kumano S, Suzuki E et al (2010) Mir-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0013614","journal-title":"PLoS ONE"},{"key":"11005_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10305","volume":"22","author":"Q-G Wang","year":"2021","unstructured":"Wang Q-G, Cheng B, He Y-Z et al (2021) miR\u2013320a in serum exosomes promotes myocardial fibroblast proliferation via regulating the PIK3CA\/Akt\/mTOR signaling pathway in HEH2 cells. Exp Ther Med 22:1\u201314. https:\/\/doi.org\/10.3892\/etm.2021.10305","journal-title":"Exp Ther Med"},{"key":"11005_CR49","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s11010-025-05253-8","volume":"480","author":"Y Ren","year":"2025","unstructured":"Ren Y, Lin H, Guo J et al (2025) Roles of micrornas in cardiorenal syndrome. Mol Cell Biochem 480:4069\u20134078. https:\/\/doi.org\/10.1007\/s11010-025-05253-8","journal-title":"Mol Cell Biochem"},{"key":"11005_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcha.2017.11.001","volume":"17","author":"A Salgado-Somoza","year":"2017","unstructured":"Salgado-Somoza A, Zhang L, Vausort M, Devaux Y (2017) The circular RNA MICRA for risk stratification after myocardial infarction. IJC Heart & Vasculature 17:33\u201336. https:\/\/doi.org\/10.1016\/j.ijcha.2017.11.001","journal-title":"IJC Heart & Vasculature"},{"key":"11005_CR51","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrneph.2016.51","volume":"12","author":"JM Lorenzen","year":"2016","unstructured":"Lorenzen JM, Thum T (2016) Long noncoding RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol 12:360\u2013373","journal-title":"Nat Rev Nephrol"},{"key":"11005_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70453","author":"X Kong","year":"2025","unstructured":"Kong X, Li F, Wang Y (2025) Emerging roles of long non-coding RNAs in cardiovascular diseases. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.70453","journal-title":"J Cell Mol Med"},{"key":"11005_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.kint.2017.02.012","volume":"92","author":"C Schauerte","year":"2017","unstructured":"Schauerte C, H\u00fcbner A, Rong S et al (2017) Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction. Kidney Int 92:646\u2013656. https:\/\/doi.org\/10.1016\/j.kint.2017.02.012","journal-title":"Kidney Int"},{"key":"11005_CR54","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1038\/s41598-017-07611-z","volume":"7","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Gao W, Long QQ et al (2017) Increased plasma levels of LncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep 7:7491. https:\/\/doi.org\/10.1038\/s41598-017-07611-z","journal-title":"Sci Rep"},{"key":"11005_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030487","volume":"10","author":"K Tzavlaki","year":"2020","unstructured":"Tzavlaki K, Moustakas A (2020) TGF-\u0392 signaling. Biomolecules 10:487. https:\/\/doi.org\/10.3390\/biom10030487","journal-title":"Biomolecules"},{"key":"11005_CR56","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/01.ATV.0000225287.20034.2c","volume":"26","author":"A Bobik","year":"2006","unstructured":"Bobik A (2006) Transforming growth factor-\u03b2s and vascular disorders. Arterioscler Thromb Vasc Biol 26:1712\u20131720. https:\/\/doi.org\/10.1161\/01.ATV.0000225287.20034.2c","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11005_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG (2007) The role of TGF-\u03b2 signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184\u2013195. https:\/\/doi.org\/10.1016\/j.cardiores.2006.10.002","journal-title":"Cardiovasc Res"},{"key":"11005_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022053","volume":"8","author":"CH Heldin","year":"2016","unstructured":"Heldin CH, Moustakas A (2016) Signaling receptors for TGF-\u03b2 family members. Cold Spring Harb Perspect Biol 8:a022053","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11005_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78206-4","volume":"10","author":"SW Clayton","year":"2020","unstructured":"Clayton SW, Ban GI, Liu C, Serra R (2020) Canonical and noncanonical TGF-\u03b2 signaling regulate fibrous tissue differentiation in the axial skeleton. Sci Rep 10:1\u201311. https:\/\/doi.org\/10.1038\/s41598-020-78206-4","journal-title":"Sci Rep"},{"key":"11005_CR60","doi-asserted-by":"publisher","first-page":"a022129","DOI":"10.1101\/cshperspect.a022129","volume":"9","author":"YE Zhang","year":"2017","unstructured":"Zhang YE (2017) Non-Smad signaling pathways of the TGF-\u03b2 family. Cold Spring Harb Perspect Biol 9:a022129","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11005_CR61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","volume":"424","author":"V Rai","year":"2017","unstructured":"Rai V, Sharma P, Agrawal S, Agrawal DK (2017) Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem 424:123\u2013145. https:\/\/doi.org\/10.1007\/s11010-016-2849-0","journal-title":"Mol Cell Biochem"},{"key":"11005_CR62","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/CS20220797","volume":"138","author":"J Toto\u0144-\u017buranska","year":"2024","unstructured":"Toto\u0144-\u017buranska J, Mikolajczyk TP, Saju B, Guzik TJ (2024) Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation. Clin Sci 138:817\u2013850. https:\/\/doi.org\/10.1042\/CS20220797","journal-title":"Clin Sci"},{"key":"11005_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/mmr.2024.13267","volume":"30","author":"J Li","year":"2024","unstructured":"Li J, Zou Y, Kantapan J et al (2024) TGF\u2013\u03b2\/Smad signaling in chronic kidney disease: exploring post\u2013translational regulatory perspectives (Review). Mol Med Rep 30:143\u20132024. https:\/\/doi.org\/10.3892\/mmr.2024.13267","journal-title":"Mol Med Rep"},{"key":"11005_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Rosa CCD, La et al (2020) The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci 21:1\u201353. https:\/\/doi.org\/10.3390\/ijms21249739","journal-title":"Int J Mol Sci"},{"key":"11005_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000362650","volume":"4","author":"GM Virz\u00ec","year":"2014","unstructured":"Virz\u00ec GM, Clementi A, Brocca A et al (2014) The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1. CardioRenal Med 4:103\u2013112","journal-title":"CardioRenal Med"},{"key":"11005_CR66","doi-asserted-by":"publisher","first-page":"a022137","DOI":"10.1101\/cshperspect.a022137","volume":"9","author":"K Luo","year":"2017","unstructured":"Luo K (2017) Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways. Cold Spring Harb Perspect Biol 9:a022137. https:\/\/doi.org\/10.1101\/cshperspect.a022137","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11005_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms13884","volume":"7","author":"J Yu","year":"2016","unstructured":"Yu J, Lei R, Zhuang X et al (2016) Microrna-182 targets SMAD7 to potentiate TGF\u03b2-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun 7:1\u201312. https:\/\/doi.org\/10.1038\/ncomms13884","journal-title":"Nat Commun"},{"key":"11005_CR68","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.bbadis.2015.04.006","volume":"1852","author":"R Garc\u00eda","year":"2015","unstructured":"Garc\u00eda R, Nistal JF, Merino D et al (2015) P-SMAD2\/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling. Biochimica et Biophysica Acta (BBA) 1852:1520\u20131530. https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.006","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"11005_CR69","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1681\/ASN.2010111168","volume":"22","author":"X Zhong","year":"2011","unstructured":"Zhong X, Chung ACK, Chen HY et al (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668\u20131681. https:\/\/doi.org\/10.1681\/ASN.2010111168","journal-title":"J Am Soc Nephrol"},{"key":"11005_CR70","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.165172","author":"E Chatterjee","year":"2023","unstructured":"Chatterjee E, Rodosthenous RS, Kujala V et al (2023) Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. JCI Insight. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.165172","journal-title":"JCI Insight"},{"key":"11005_CR71","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1007\/s00432-023-04747-6","volume":"149","author":"T Alinejad","year":"2023","unstructured":"Alinejad T, Modarressi S, Sadri Z et al (2023) Diagnostic applications and therapeutic option of cascade crispr\/cas in the modulation of miRNA in diverse cancers: promises and obstacles. J Cancer Res Clin Oncol 149:9557\u20139575. https:\/\/doi.org\/10.1007\/s00432-023-04747-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"11005_CR72","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.ackd.2018.08.006","volume":"25","author":"J Rangaswami","year":"2018","unstructured":"Rangaswami J, Mathew RO (2018) Pathophysiological mechanisms in cardiorenal syndrome. Adv Chronic Kidney Dis 25:400\u2013407","journal-title":"Adv Chronic Kidney Dis"},{"key":"11005_CR73","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccl.2020.01.004","volume":"38","author":"T Tabucanon","year":"2020","unstructured":"Tabucanon T, Tang WHW (2020) Right heart failure and cardiorenal syndrome. Cardiol Clin 38:185\u2013202. https:\/\/doi.org\/10.1016\/j.ccl.2020.01.004","journal-title":"Cardiol Clin"},{"key":"11005_CR74","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","volume":"53","author":"K Damman","year":"2009","unstructured":"Damman K, van Deursen VM, Navis G et al (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582\u2013588. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.080","journal-title":"J Am Coll Cardiol"},{"key":"11005_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-2770-5","volume":"24","author":"CY Chen","year":"2020","unstructured":"Chen CY, Zhou Y, Wang P et al (2020) Elevated central venous pressure is associated with increased mortality and acute kidney injury in critically ill patients: a meta-analysis. Crit Care 24:1\u20138. https:\/\/doi.org\/10.1186\/s13054-020-2770-5","journal-title":"Crit Care"},{"key":"11005_CR76","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","volume":"51","author":"W Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated Intra-Abdominal pressure in acute decompensated heart failure. A potential contributor to worsening renal function?? J Am Coll Cardiol 51:300\u2013306. https:\/\/doi.org\/10.1016\/j.jacc.2007.09.043","journal-title":"J Am Coll Cardiol"},{"key":"11005_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bcp.13434","volume":"84","author":"A Al-Naher","year":"2018","unstructured":"Al-Naher A, Wright D, Devonald MAJ, Pirmohamed M (2018) Renal function monitoring in heart failure \u2013 what is the optimal frequency? A narrative review. Br J Clin Pharmacol 84:5\u201317. https:\/\/doi.org\/10.1111\/bcp.13434","journal-title":"Br J Clin Pharmacol"},{"key":"11005_CR78","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","volume":"51","author":"A Nohria","year":"2008","unstructured":"Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions. Insights from the ESCAPE trial. J Am Coll Cardiol 51:1268\u20131274. https:\/\/doi.org\/10.1016\/j.jacc.2007.08.072","journal-title":"J Am Coll Cardiol"},{"key":"11005_CR79","doi-asserted-by":"publisher","unstructured":"Min K, Matsumoto Y, Failure MA-EH, Matsumoto undefined, Asakura M (2024) M IshiharaESC Hear Fail 2024\u2022Wiley Online Libr 11:3470\u20133487. https:\/\/doi.org\/10.1002\/ehf2.14811","DOI":"10.1002\/ehf2.14811"},{"key":"11005_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-015-0068-7","volume":"16","author":"BT Lee","year":"2015","unstructured":"Lee BT, Ahmed FA, Hamm LL et al (2015) Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol 16:1\u20136","journal-title":"BMC Nephrol"},{"key":"11005_CR81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1536\/jhj.45.183","volume":"45","author":"T Kanda","year":"2004","unstructured":"Kanda T, Takahashi T (2004) Interleukin-6 and cardiovascular diseases. Jpn Hear J 45:183\u2013193","journal-title":"Jpn Hear J"},{"key":"11005_CR82","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","volume":"24","author":"DM Silverstein","year":"2009","unstructured":"Silverstein DM (2009) Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24:1445\u20131452. https:\/\/doi.org\/10.1007\/s00467-008-1046-0","journal-title":"Pediatr Nephrol"},{"key":"11005_CR83","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.amjcard.2017.12.046","volume":"121","author":"Y Minami","year":"2018","unstructured":"Minami Y, Kajimoto K, Sato N, Hagiwara N (2018) Effect of elevated C-reactive protein level at discharge on long-term outcome in patients hospitalized for acute heart failure. Am J Cardiol 121:961\u2013968. https:\/\/doi.org\/10.1016\/j.amjcard.2017.12.046","journal-title":"Am J Cardiol"},{"key":"11005_CR84","unstructured":"Mustafa B, Shmesat M Investigation of IL-25, pentraxin 3, adiponectin, and CRP levels in serum of Chronic Kidney Patients"},{"key":"11005_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00363","volume":"8","author":"C Peir\u00f3","year":"2017","unstructured":"Peir\u00f3 C, Lorenzo \u00f3scar, Carraro R, S\u00e1nchez-Ferrer CF (2017) IL-1\u03b2 inhibition in cardiovascular complications associated to diabetes mellitus. Front Pharmacol 8:363. https:\/\/doi.org\/10.3389\/fphar.2017.00363","journal-title":"Front Pharmacol"},{"key":"11005_CR86","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4049\/jimmunol.1001328","volume":"186","author":"PY Lee","year":"2011","unstructured":"Lee PY, Kumagai Y, Xu Y et al (2011) IL-1\u03b1 modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oil. J Immunol 186:1747\u20131754. https:\/\/doi.org\/10.4049\/jimmunol.1001328","journal-title":"J Immunol"},{"key":"11005_CR87","doi-asserted-by":"publisher","unstructured":"Trimarco V, Izzo R, Pacella D et al (2024) Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study. Diabetes Res Clin Pract 218. https:\/\/doi.org\/10.1016\/J.DIABRES.2024.111926","DOI":"10.1016\/J.DIABRES.2024.111926"},{"key":"11005_CR88","doi-asserted-by":"publisher","unstructured":"Pepper GS, Lee RW (1999) Sympathetic activation in heart failure and its treatment with \u03b2- blockade. Arch Intern Med 159:225\u2013234. https:\/\/doi.org\/10.1001\/archinte.159.3.225","DOI":"10.1001\/archinte.159.3.225"},{"key":"11005_CR89","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","volume":"63","author":"VJ Dzau","year":"1981","unstructured":"Dzau VJ, Colucci WS, Hollenberg NK, Williams GH (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63:645\u2013651. https:\/\/doi.org\/10.1161\/01.CIR.63.3.645","journal-title":"Circulation"},{"key":"11005_CR90","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10741-012-9368-1","volume":"19","author":"Y Wang","year":"2014","unstructured":"Wang Y, Seto SW, Golledge J (2014) Angiotensin II, sympathetic nerve activity and chronic heart failure. Heart Fail Rev 19:187\u2013198. https:\/\/doi.org\/10.1007\/s10741-012-9368-1","journal-title":"Heart Fail Rev"},{"key":"11005_CR91","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00259-022-05941-3","volume":"50","author":"P Gargiulo","year":"2023","unstructured":"Gargiulo P, Acampa W, Asile G et al (2023) 123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation. Eur J Nucl Med Mol Imaging 50:813\u2013824. https:\/\/doi.org\/10.1007\/s00259-022-05941-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11005_CR92","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.3390\/cells11213336","volume":"11","author":"SK Bhullar","year":"2022","unstructured":"Bhullar SK, Dhalla NS (2022) Angiotensin II-induced signal transduction mechanisms for cardiac hypertrophy. Cells 11:3336. https:\/\/doi.org\/10.3390\/cells11213336","journal-title":"Cells"},{"key":"11005_CR93","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/jvim.15454","volume":"33","author":"MK Ames","year":"2019","unstructured":"Ames MK, Atkins CE, Pitt B (2019) The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med 33:363\u2013382. https:\/\/doi.org\/10.1111\/jvim.15454","journal-title":"J Vet Intern Med"},{"key":"11005_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-030-63046-1_2","volume":"1303","author":"SA Barman","year":"2021","unstructured":"Barman SA, Bordan Z, Batori R et al (2021) Galectin-3 promotes ROS, inflammation, and vascular fibrosis in pulmonary arterial hypertension. Adv Exp Med Biol 1303:13\u201332. https:\/\/doi.org\/10.1007\/978-3-030-63046-1_2","journal-title":"Adv Exp Med Biol"},{"key":"11005_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/JCDD11020062","author":"T Chiuariu","year":"2024","unstructured":"Chiuariu T, \u0218alaru D, Ureche C et al (2024) Cardiac and renal fibrosis, the silent killer in the cardiovascular continuum: an up-to-date. J Cardiovasc Dev Dis. https:\/\/doi.org\/10.3390\/JCDD11020062","journal-title":"J Cardiovasc Dev Dis"},{"key":"11005_CR96","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","volume":"40","author":"MO Gray","year":"1998","unstructured":"Gray MO, Long CS, Kalinyak JE et al (1998) Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-\u03b21 and endothelin-1 from fibroblasts. Cardiovasc Res 40:352\u2013363. https:\/\/doi.org\/10.1016\/S0008-6363(98)00121-7","journal-title":"Cardiovasc Res"},{"key":"11005_CR97","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1089\/ars.2012.4604","volume":"19","author":"SI Dikalov","year":"2013","unstructured":"Dikalov SI, Nazarewicz RR (2013) Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal 19:1085\u20131094. https:\/\/doi.org\/10.1089\/ars.2012.4604","journal-title":"Antioxid Redox Signal"},{"key":"11005_CR98","doi-asserted-by":"publisher","unstructured":"Ma K, Gao W, Xu H et al (2022) Role and mechanism of the Renin-Angiotensin-Aldosterone system in the onset and development of cardiorenal syndrome. https:\/\/doi.org\/10.1155\/2022\/3239057. JRAAS - J Renin-Angiotensin-Aldosterone Syst 2022:","DOI":"10.1155\/2022\/3239057"},{"key":"11005_CR99","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/jpet.114.218370","volume":"351","author":"LC Li","year":"2014","unstructured":"Li LC, Li J, Gao J (2014) Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther 351:336\u2013343. https:\/\/doi.org\/10.1124\/jpet.114.218370","journal-title":"J Pharmacol Exp Ther"},{"key":"11005_CR100","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/EHF2.15042","volume":"12","author":"H Nishi","year":"2025","unstructured":"Nishi H, Nangaku M, Sofue T et al (2025) N-terminal pro-brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease. ESC Heart Fail 12:848\u2013858. https:\/\/doi.org\/10.1002\/EHF2.15042","journal-title":"ESC Heart Fail"},{"key":"11005_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102407","volume":"20","author":"F Collin","year":"2019","unstructured":"Collin F (2019) Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int J Mol Sci 20:2407. https:\/\/doi.org\/10.3390\/ijms20102407","journal-title":"Int J Mol Sci"},{"key":"11005_CR102","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.jacc.2009.12.046","volume":"55","author":"M Haase","year":"2010","unstructured":"Haase M, Bellomo R, Haase-Fielitz A (2010) Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 55:2024\u20132033. https:\/\/doi.org\/10.1016\/j.jacc.2009.12.046","journal-title":"J Am Coll Cardiol"},{"key":"11005_CR103","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000184","volume":"2","author":"F Qin","year":"2013","unstructured":"Qin F, Siwik DA, Lancel S et al (2013) Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart. J Am Heart Assoc 2:e000184. https:\/\/doi.org\/10.1161\/JAHA.113.000184","journal-title":"J Am Heart Assoc"},{"key":"11005_CR104","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.RES.87.5.392","volume":"87","author":"S Kinugawa","year":"2000","unstructured":"Kinugawa S, Tsutsui H, Hayashidani S et al (2000) Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res 87:392\u2013398. https:\/\/doi.org\/10.1161\/01.RES.87.5.392","journal-title":"Circ Res"},{"key":"11005_CR105","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/antiox10081306","volume":"10","author":"T Maruhashi","year":"2021","unstructured":"Maruhashi T, Higashi Y (2021) Pathophysiological association between diabetes mellitus and endothelial dysfunction. Antioxidants 10:1306. https:\/\/doi.org\/10.3390\/antiox10081306","journal-title":"Antioxidants"},{"key":"11005_CR106","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/ars.2012.4641","volume":"19","author":"A Nguyen Dinh Cat","year":"2013","unstructured":"Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM (2013) Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal 19:1110\u20131120. https:\/\/doi.org\/10.1089\/ars.2012.4641","journal-title":"Antioxid Redox Signal"},{"key":"11005_CR107","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000452283","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Bottiglieri T, Mccullough PA (2017) The central role of endothelial dysfunction in cardiorenal syndrome. CardioRenal Med 7:104\u2013117","journal-title":"CardioRenal Med"},{"key":"11005_CR108","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/CS20050067","volume":"109","author":"R Ray","year":"2005","unstructured":"Ray R, Shah AM (2005) NADPH oxidase and endothelial cell function. Clin Sci 109:217\u2013226. https:\/\/doi.org\/10.1042\/CS20050067","journal-title":"Clin Sci"},{"key":"11005_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/hdy.2010.54","volume":"105","author":"ER Gibney","year":"2010","unstructured":"Gibney ER, Nolan CM (2010) Epigenetics and gene expression. Heredity (Edinb) 105:4\u201313. https:\/\/doi.org\/10.1038\/hdy.2010.54","journal-title":"Heredity (Edinb)"},{"key":"11005_CR110","doi-asserted-by":"publisher","unstructured":"Hulshoff M, Xu X, thrombosis GK-\u2026 et al (2018) Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease: histone modifications, DNA methylation, and noncoding RNAs. ahajournals.org 38:1986\u20131996. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311276","DOI":"10.1161\/ATVBAHA.118.311276"},{"key":"11005_CR111","unstructured":"Li H, Liu T, Yang Y et al Interplays of liver fibrosis-associated micrornas: molecular mechanisms and implications in diagnosis and therapy. Elsevier"},{"key":"11005_CR112","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1152\/physiolgenomics.00070.2016","volume":"48","author":"CA Drummond","year":"2016","unstructured":"Drummond CA, Crotty Alexander LE, Haller ST et al (2016) Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosis. Physiol Genomics 48:950\u2013960. https:\/\/doi.org\/10.1152\/physiolgenomics.00070.2016","journal-title":"Physiol Genomics"},{"key":"11005_CR113","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00125-012-2804-x","volume":"56","author":"X Zhong","year":"2013","unstructured":"Zhong X, Chung ACK, Chen HY et al (2013) Mir-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56:663\u2013674. https:\/\/doi.org\/10.1007\/s00125-012-2804-x","journal-title":"Diabetologia"},{"key":"11005_CR114","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.15252\/emmm.201303604","volume":"6","author":"RL Montgomery","year":"2014","unstructured":"Montgomery RL, Yu G, Latimer PA et al (2014) Micro RNA mimicry blocks pulmonary fibrosis. EMBO Mol Med 6:1347\u20131356. https:\/\/doi.org\/10.15252\/emmm.201303604","journal-title":"EMBO Mol Med"},{"key":"11005_CR115","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/mt.2012.35","volume":"20","author":"L Wang","year":"2012","unstructured":"Wang L, Zhou L, Jiang P et al (2012) Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 20:1222\u20131233. https:\/\/doi.org\/10.1038\/mt.2012.35","journal-title":"Mol Ther"},{"key":"11005_CR116","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1093\/eurheartj\/ehac463","volume":"43","author":"AM Shah","year":"2022","unstructured":"Shah AM, Giacca M (2022) Small non-coding RNA therapeutics for cardiovascular disease. Eur Heart J 43:4548\u20134561. https:\/\/doi.org\/10.1093\/eurheartj\/ehac463","journal-title":"Eur Heart J"},{"key":"11005_CR117","doi-asserted-by":"publisher","first-page":"22442","DOI":"10.1038\/srep22442","volume":"6","author":"BC Bernardo","year":"2016","unstructured":"Bernardo BC, Nguyen SS, Gao XM et al (2016) Inhibition of miR-154 protects against cardiac dysfunction and fibrosis in a mouse model of pressure overload. Sci Rep 6:22442. https:\/\/doi.org\/10.1038\/srep22442","journal-title":"Sci Rep"},{"key":"11005_CR118","doi-asserted-by":"publisher","first-page":"347","DOI":"10.18632\/aging.100558","volume":"5","author":"R Singhal","year":"2013","unstructured":"Singhal R, Bard JE, Nowak NJ et al (2013) FOXO1 regulates expression of a microrna cluster on X chromosome. Aging 5:347\u2013356. https:\/\/doi.org\/10.18632\/aging.100558","journal-title":"Aging"},{"key":"11005_CR119","doi-asserted-by":"publisher","unstructured":"Dharini AG, Kejamurthy P, Ramya Devi KT Co-regulation of miRNA and lncRNA on immunosuppression gene: unveiling the regulatory networks in cancer. Nucleosides, Nucleotides and, Acids N (2025) https:\/\/doi.org\/10.1080\/15257770.2025.2514129","DOI":"10.1080\/15257770.2025.2514129"},{"key":"11005_CR120","doi-asserted-by":"publisher","unstructured":"Yanai K, Kaneko S, Ishii H et al (2022) Delivery of exogenous artificially synthesized MiRNA mimic to the kidney using polyethylenimine nanoparticles in several kidney disease mouse models. https:\/\/doi.org\/10.3791\/63302. J Vis Exp 2022:","DOI":"10.3791\/63302"},{"key":"11005_CR121","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1166\/jbn.2022.3261","volume":"18","author":"W Gao","year":"2022","unstructured":"Gao W, Liang L (2022) Effect of polysaccharide sulfate-loaded poly(lactic-co-glycolic acid) nanoparticles on coronary microvascular dysfunction of diabetic cardiomyopathy. J Biomed Nanotechnol 18:446\u2013452. https:\/\/doi.org\/10.1166\/jbn.2022.3261","journal-title":"J Biomed Nanotechnol"},{"key":"11005_CR122","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","volume":"124","author":"RL Montgomery","year":"2011","unstructured":"Montgomery RL, Hullinger TG, Semus HM et al (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124:1537\u20131547. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.030932","journal-title":"Circulation"},{"key":"11005_CR123","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ajpath.2012.08.022","volume":"181","author":"T Wang","year":"2012","unstructured":"Wang T, Feng Y, Sun H et al (2012) Mir-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol 181:1911\u20131920. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.022","journal-title":"Am J Pathol"},{"key":"11005_CR124","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1128\/IAI.01495-14","volume":"82","author":"C McClure","year":"2014","unstructured":"McClure C, Brudecki L, Ferguson DA et al (2014) Microrna 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect Immun 82:3816\u20133825. https:\/\/doi.org\/10.1128\/IAI.01495-14","journal-title":"Infect Immun"},{"key":"11005_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30803","volume":"10","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xue Y, Zhang H (2024) Suppression of gastric cancer cell proliferation by miR-494-3p inhibitor-loaded engineered exosomes. Heliyon 10:e30803. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30803","journal-title":"Heliyon"},{"key":"11005_CR126","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1517\/14728222.2014.975794","volume":"19","author":"M Garg","year":"2015","unstructured":"Garg M (2015) Targeting micrornas in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opin Ther Targets 19:285\u2013297. https:\/\/doi.org\/10.1517\/14728222.2014.975794","journal-title":"Expert Opin Ther Targets"},{"key":"11005_CR127","doi-asserted-by":"publisher","unstructured":"Shams E, Bonnice S, Mayrovitz HN (2022) Diuretic resistance associated with heart failure. https:\/\/doi.org\/10.7759\/cureus.21369. Cureus 14:","DOI":"10.7759\/cureus.21369"},{"key":"11005_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000322822","volume":"1","author":"JR Sowers","year":"2011","unstructured":"Sowers JR, Whaley-Connell A, Hayden MR (2011) The role of overweight and obesity in the cardiorenal syndrome. CardioRenal Med 1:5\u201312. https:\/\/doi.org\/10.1159\/000322822","journal-title":"CardioRenal Med"},{"key":"11005_CR129","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/21548331.2021.1893065","volume":"50","author":"SG Chrysant","year":"2022","unstructured":"Chrysant SG, Chrysant GS (2022) The pathophysiology and management of diuretic resistance in patients with heart failure. Hosp Pract 50:93\u2013101. https:\/\/doi.org\/10.1080\/21548331.2021.1893065","journal-title":"Hosp Pract"},{"key":"11005_CR130","doi-asserted-by":"publisher","unstructured":"Htoo P, Tesfaye H, Schneeweiss S et al (2024) Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. SpringerPT Htoo, H Tesfaye, S Schneeweiss, DJ Wexler, BM Everett, RJ Glynn, N SchmedtCardiovascular Diabetol 2024\u2022Springer 23:. https:\/\/doi.org\/10.1186\/s12933-024-02150-0","DOI":"10.1186\/s12933-024-02150-0"},{"key":"11005_CR131","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1124\/JPET.123.001692","volume":"387","author":"S Ito","year":"2023","unstructured":"Ito S, Yamatani F, Arai Y et al (2023) Dimethyl fumarate ameliorated cardiorenal anemia syndrome and improved overall survival in Dahl\/Salt-Sensitive rats. J Pharmacol Exp Ther 387:299\u2013305. https:\/\/doi.org\/10.1124\/JPET.123.001692","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11005-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11005-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11005-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:26Z","timestamp":1766898206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11005-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11005"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11005-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"909"}}